European Leukemia Trial Registry
Trial: MDS Romiplostim

More Details
Title Romiplostim Treatment of Thrombocytopenia in MDS
Scientific Title A Randomized, Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS
Short Title MDS Romiplostim
Trialgroup Deutsche MDS
Type of Trial multicentric, randomized
Disease Myelodysplastic Syndrome(MDS) Low risk and intermedia I
Age All ages
Status Closed
Start of Recruitment 15.05.2008
Leader Ganser, Prof. Dr. med., Arnold
Centre of Trial Medizinische Hochschule Hannover (MHH)
Shortprotocol Shortprotocol
created 03.02.2009 Roswitha Kotthoff
changed 10.07.2013 Sina Hehn
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |